ASH 2022 Conference Coverage
Phase 3b, Single-Arm, Multicenter Study to Assess the Efficacy, Safety, & Tolerability of Ropeginterferon Alfa-2b-Njft (P1101) in Adult Patients With Polycythemia Vera
By
ASH 2022 Conference Coverage
FEATURING
John Mascarenhas
By
ASH 2022 Conference Coverage
FEATURING
John Mascarenhas
Login to view comments.
Click here to Login
